Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Cardinal Health (CAH – Research Report) received a Buy rating and a $144.00 price target from TD Cowen analyst Charles Rhyee today. The ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...

Cardinal Health (CAH – Research Report) received a Buy rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

The Dublin healthcare giant reported $226.8 billion in sales for FY24 that ended June 30, the ninth consecutive year of ...

Learn more about whether Cardinal Health, Inc. or Fresenius Medical Care AG is a better investment based on AAII's A+ ...

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Cardinal Health (NYSE:CAH) from Neutral ...

In the most recent trading session, Cardinal Health (CAH) closed at $117.92, indicating a -1.02% shift from the previous trading day.

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

Learn more about whether Cardinal Health, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...

Bank of America upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat.com reports. Bank of America currently has ...

Healthcare Distribution Market is estimated to be valued at USD 1,050.2 Bn in 2024 and is expected to reach USD 1,633.1 Bn by 2031, exhibiting a CAGR of 6.5%. Mr. Shah Coherent Market Insights Pvt.